Lorrain Daniel S.'s Form 4 filing
Contineum Therapeutics, Inc. (CTNM) · filed May 1, 2026
- Accession no.
- 0001628280-26-029435
- Filed
- May 1, 2026
- Trade date
- May 1, 2026
- Filing delay
- Same day
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $54.7K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lorrain Daniel S.CIK 0001861550 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 1, 2026 | Class A Common Stock | SSaleDisposed | −3,870 | $13.06 | −$50,542.2 | 143,842 | Direct | |
| May 1, 2026 | Class A Common Stock | SSaleDisposed | −300 | $13.84 | −$4,152 | 143,542 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.